• Home
  • Privacy Policy
  • About/ Contact
The Markets Daily logo
  • Business
  • Stocks
  • Technology
  • Health
  • Lifestyle
  • Politics
Klabin (OTCMKTS:KLBAY) Stock Passes Above Two Hundred Day Moving Average of $10.01

Klabin (OTCMKTS:KLBAY) Stock Passes Above Two Hundred Day Moving Average of $10.01

Apr 16th, 2021

Klabin S.A. (OTCMKTS:KLBAY) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $10.01 and traded as high as $11.00. Klabin... 
Input Capital (CVE:INP) Stock Price Passes Below 200-Day Moving Average of $1.00

Input Capital (CVE:INP) Stock Price Passes Below 200-Day Moving Average of $1.00

Apr 16th, 2021

Shares of Input Capital Corp. (CVE:INP) crossed below its 200-day moving average... 

Hummingbird Resources (LON:HUM) Share Price Passes Below Two Hundred Day Moving Average of $29.17

Hummingbird Resources (LON:HUM) Share Price Passes Below Two Hundred Day Moving Average of $29.17

Apr 16th, 2021

Hummingbird Resources PLC (LON:HUM)’s share price crossed below its 200-day... 

Nasdaq (NASDAQ:NDAQ) Hits New 1-Year High After Analyst Upgrade

Nasdaq (NASDAQ:NDAQ) Hits New 1-Year High After Analyst Upgrade

Apr 16th, 2021

Nasdaq, Inc. (NASDAQ:NDAQ) hit a new 52-week high during trading on Wednesday... 

Euronav (NYSE:EURN) Downgraded by ING Group

Euronav (NYSE:EURN) Downgraded by ING Group

Apr 16th, 2021

ING Group cut shares of Euronav (NYSE:EURN) from a buy rating to a hold rating... 

Health

Diabetes Patients and Advocates Fight Back Against Skyrocketing Insulin Prices

Sep 13th, 2017

Diabetes Patients and Advocates Fight Back Against Skyrocketing Insulin Prices

Roughly 6 million people in the United States need insulin injections because they have diabetes, 1.25 million have Type 1.  This is a condition characterized by... 

More »

  • Mylan Slashes Forecasts Due to Weak Prices and Delay in Drugs
  • Novocure Glioblastoma Treatment Trial Shows Extremely Promising Results
  • EpiPen Maker Mylan Pharma Expands March Recall of Auto-Injectors
  • Elephant Tranquilizer Could Be Next Drug Epidemic
  • Rush University Scientist Investigates Effect of “Time Tax” On Snack Choices

Politics

Drama on Capitol Hill Not Affecting Wall Street

Jul 16th, 2017

Drama on Capitol Hill Not Affecting Wall Street

Wall Street is not showing any concern about what is taking place in Washington. The stock market continues to rewrite the record books despite ongoing legislative... 

More »

  • White House Ready to Place Big Tariffs on Steel
  • US Department of the Interior Reopens Coal Mining Operations

Technology

Cisco Revenue from Security Business Comes Up Short

Aug 17th, 2017

Cisco Revenue from Security Business Comes Up Short

Cisco Systems quarterly revenue for its security business came up short of estimates by analysts, raising the concern about the largest networking gear maker in... 

More »

  • Jawbone at One Time Worth $3 Billion, Now Shutting Down
  • Samsung Overtaking Intel in Chip Race
  • Google Increases Measures Made to Remove Extremist Content
  • Snapchat Introduces New Public Search Feature
  • Mad Catz Files Chapter 7 Bankruptcy

Lifestyle

How Strong Do You Like Your Coffee?

Apr 1st, 2017

How Strong Do You Like Your Coffee?

Just how much caffeine is too much? Well, US residents may be a little better informed to answer this question as the “world’s strongest coffee” is now... 

More »



Follow @TheMarketsDaily

Recent Posts

  • Klabin (OTCMKTS:KLBAY) Stock Passes Above Two Hundred Day Moving Average of $10.01
  • Input Capital (CVE:INP) Stock Price Passes Below 200-Day Moving Average of $1.00
  • Hummingbird Resources (LON:HUM) Share Price Passes Below Two Hundred Day Moving Average of $29.17
  • Nasdaq (NASDAQ:NDAQ) Hits New 1-Year High After Analyst Upgrade
  • Euronav (NYSE:EURN) Downgraded by ING Group
  • Evelo Biosciences (NASDAQ:EVLO) Upgraded at Jefferies Financial Group
  • Equities Analysts Offer Predictions for Repsol, S.A.’s Q1 2021 Earnings (OTCMKTS:REPYY)
  • The Duckhorn Portfolio (NYSE:NAPA) Earns Buy Rating from Analysts at Jefferies Financial Group
  • OMV Aktiengesellschaft (OTCMKTS:OMVJF) Forecasted to Earn Q1 2021 Earnings of $0.97 Per Share
  • Jefferies Financial Group Comments on Invesco Ltd.’s Q1 2021 Earnings (NYSE:IVZ)
  • Equities Analysts Offer Predictions for CURO Group Holdings Corp.’s Q1 2021 Earnings (NYSE:CURO)
  • Q1 2021 EPS Estimates for Federated Hermes, Inc. (NYSE:FHI) Boosted by Analyst
  • Q1 2021 EPS Estimates for Argonaut Gold Inc. (TSE:AR) Decreased by Cormark
  • Reviewing Dynatrace (NYSE:DT) & CareCloud (NASDAQ:MTBC)
  • Cogeco Communications (TSE:CCA) PT Raised to C$121.00 at Royal Bank of Canada
  • CIBC Boosts ARC Resources (TSE:ARX) Price Target to C$12.00
  • Aphria (TSE:APH) Downgraded by Pi Financial
  • Morgan Stanley Reiterates “CHF 24” Price Target for ABB (VTX:ABBN)
  • Amdocs (NASDAQ:DOX) versus RumbleON (NASDAQ:RMBL) Financial Review
  • JPMorgan Chase & Co. Analysts Give Befesa (ETR:BFSA) a €57.00 Price Target
  • Business
  • Stocks
  • Technology
  • Health
  • Lifestyle
  • Politics
© 2006-2021 Markets Daily